— Know what they know.
Not Investment Advice
Also trades as: TSTL.L (LSE) · $vol 1M

TSNLF OTC

Tristel PLC
1W: +0.0% 1M: +0.0% 3M: +3.8% YTD: +11.7% 1Y: +8.5% 3Y: +18.8% 5Y: +537.6%
$5.74
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Instruments & Supplies · Tech Score Sell · Power 46 · $275.5M mcap · 47M float · 0.0001% daily turnover · Short 100% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$275.5M
52W Range5-6
Volume400
Avg Volume54
Beta0.34
Dividend$0.19
Analyst Ratings
0 Buy 1 Hold 0 Sell
Consensus Hold
Company Info
CEOChristopher Paul Lee
Employees267
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2014-07-17
Lynx Business Park
Snailwell, EA CB8 7NY
GB
+44 1638 721500
About Tristel PLC

Operating both within the United Kingdom and globally, Tristel plc specializes in the development, production, and distribution of products designed for infection control. Its business is structured into three primary divisions: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and a third, unnamed 'Other' segment. Under its proprietary Tristel brand, the firm provides a comprehensive range of medical instrument disinfection solutions. These cater to a diverse array of applications, such as airway management, cardiology, ENT, endoscopy, gastrointestinal physiology, laboratory use, ophthalmology, phlebotomy, reproductive health/IVF, surface disinfection, ultrasound, urology, and women's health, alongside other related offerings. Established in 1993, Tristel plc maintains its headquarters in Snailwell, United Kingdom.

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms